Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,531.00    1.00 (0.07%)
Bid:
1,531.00
Ask:
1,532.00
Spread: 1.00 (0.065%)
Market Cap: £3.22b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Hikma Pharmaceuticals News

Hikma Pharmaceutical falls on guidance miss but Peel Hunt says 'buy'
24 Feb 2022

Hikma Pharmaceutical falls on guidance miss but Peel Hunt says 'buy'

(Alliance News) - Shares in Hikma Pharmaceutical PLC fell on Thursday along with the rest of the London market, despite having no obvious exposure to ...

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout
24 Feb 2022

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and ...

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'
24 Feb 2022

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strate...

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma
24 Feb 2022

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale wa...

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo
9 Feb 2022

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Hikma completes acquisition of Teligent's Canadian assets
3 Feb 2022

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million
17 Jan 2022

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million